But not everyone shares this view. Survival curves in similar blood cancers, such as leukaemia and lymphoma, level out over time — the hallmark of a cure in the cancer field. This doesn't happen in patients undergoing treatment for multiple myeloma. So Rajkumar argues that some myeloma resear...
Stem cell transplantationhas potential in many different areas of health and medical research. Advanced facilities for stem cell therapy, as well as effective and reasonable guidelines and strategies for stemcell transplantin different regions are of great importance for the realization and enhancement of...
Should HIV-positive patients with lymphoma be offered stem cell transplants? Advances in effective antiretroviral therapy for HIV infection have made high-dose therapy and autologous stem cell transplantation possible in patients wi... A Krishnan,J Zaia,SJ Forman - 《Bone Marrow Transplantation》 被...
Most patients receive first-line treatment with anthracycline-based chemotherapy regimens with a potential role for consolidation with autologous stem cell transplantation (ASCT). In this study we analyzed survival outcomes in TfH lymphoma.Methods:This is an IRB approved retrospective analysis of patients...
Rituximab After Stem Cell Transplant Boosts Survival in Mantle Cell LymphomaLourdes Briz
et al. Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment. Bone Marrow Transplant 55, 117–125 (2020). https://doi.org/10.1038/s41409-019-0640-z Download citation Received07 February 2019 Revised26 July ...
celltransplantationclinicaltrialsMantle cell lymphoma (MCL) is an aggressive form of non‐Hodgkin lymphoma that remains incurable for the majority of patients. Allogeneic stem cell transplantation (alloSCT) produces long‐term disease‐free remissions for around 30–40% patients, however it is reserved...
In relapsed or refractory non-Hodgkin lymphoma (NHL), allogeneic hematopoietic stem cell transplantation (allo-HSCT) provides graft-versus-lymphoma activity resulting in fewer incidences of relapse. However, therapy-related mortality (TRM) remains an important challenge. We attempted to introduce our re...
Patients with advanced-stage follicular lymphoma (FL) are considered to be incurable and eventually relapse after conventional chemotherapy. High-dose therapy (HDT) followed by autologous hematopoietic stem cell transplantation (AHSCT) can unequivocally prolong the disease-free survival (DFS) but not ove...
stem cell transplant compared to aggressive conventional chemotherapy in relapsed chemosensitive Hodgkin lymphoma. However, the overall survival was not significantly different between the two groups.[7]CIBMTR reports that his group of malignancies accounts for the second highest number of HPSCTs in the...